SAR 89.9
(-4.36%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 62.19 Million | 58.04 Million | 52.24 Million | 53.44 Million | 50.52 Million |
Cost of Revenue | 35.42 Million | 34.67 Million | 30.2 Million | 30.25 Million | 28.51 Million |
Gross Profit | 26.76 Million | 23.36 Million | 22.03 Million | 23.18 Million | 22.01 Million |
Operating Expenses | 20.73 Million | 19.2 Million | 16 Million | 13.37 Million | 12.62 Million |
Selling, General and Administrative Expenses | 20.73 Million | 6.42 Million | 3.9 Million | 13.37 Million | 13.03 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | -169.02 Thousand | 515.74 Thousand | 555.1 Thousand | - | - |
Cost and Expenses | 56.12 Million | 53.87 Million | 46.2 Million | 43.63 Million | 41.13 Million |
Operating Income | 6.06 Million | 4.08 Million | 6.03 Million | 9.81 Million | 8.98 Million |
Interest Expense | 311.76 Thousand | 321.07 Thousand | 191.56 Thousand | 111.31 Thousand | - |
Income Tax Expense | 548.33 Thousand | 506.1 Thousand | 410.62 Thousand | 640 Thousand | 1.03 Million |
Earnings before Tax | 6.54 Million | 4.27 Million | 6.42 Million | 10.02 Million | 9.39 Million |
Net Income | 5.99 Million | 3.77 Million | 6.01 Million | 9.38 Million | 8.35 Million |
Earnings Per Share Basic | 4.25 | 2.68 | 4.27 | 6.65 | - |
Earnings Per Share Diluted | 4.25 | 2.68 | 4.27 | 6.65 | - |
Weighted Average Shares Outstanding | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million | - |
Weighted Average Shares Outstanding (Diluted) | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million | - |
Gross Margin | 0.43 | 0.40 | 0.42 | 0.43 | 0.44 |
EBIT Margin | 0.16 | 0.14 | 0.20 | 0.25 | 0.24 |
Profit Margin | 0.10 | 0.07 | 0.12 | 0.18 | 0.17 |
EBITDA | 10.22 Million | 8.01 Million | 10.14 Million | 12.98 Million | 12.2 Million |
Earnings Before Tax Margin | 0.10 | 0.07 | 0.12 | 0.18 | 0.18 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 14.7 Million | 14.7 Million | 16.08 Million | 62.19 Million | 16.08 Million | 30.02 Million |
Cost of Revenue | 7.34 Million | 7.34 Million | 8.97 Million | 35.42 Million | 8.97 Million | 16.51 Million |
Gross Profit | 7.36 Million | 7.36 Million | 7.1 Million | 26.76 Million | 7.1 Million | 13.51 Million |
Operating Expenses | 5.78 Million | 5.78 Million | 5.14 Million | 20.73 Million | 5.13 Million | 11.37 Million |
Selling, General and Administrative Expenses | 5.78 Million | 5.78 Million | 5.22 Million | - | 5.22 Million | 11.37 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | -84.51 Thousand | 927.3 Thousand | - | - |
Cost and Expenses | 13.12 Million | 13.12 Million | 14.12 Million | 56.16 Million | 14.11 Million | 27.88 Million |
Operating Income | 1.58 Million | 1.58 Million | 1.96 Million | 6.03 Million | 1.87 Million | 2.13 Million |
Interest Expense | - | - | - | 311.76 Thousand | - | 268.62 Thousand |
Income Tax Expense | 142.5 Thousand | 142.5 Thousand | 141.97 Thousand | 548.33 Thousand | 141.97 Thousand | 264.37 Thousand |
Earnings before Tax | 1.65 Million | 1.65 Million | 2.09 Million | 6.54 Million | 2.09 Million | 2.35 Million |
Net Income | 1.5 Million | 1.5 Million | 1.95 Million | 5.99 Million | 1.95 Million | 2.08 Million |
Earnings Per Share Basic | 1.07 | 1.07 | 1.39 | - | 1.39 | 1.48 |
Earnings Per Share Diluted | 1.07 | 1.07 | 1.39 | - | 1.39 | 1.48 |
Weighted Average Shares Outstanding | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million |
Weighted Average Shares Outstanding (Diluted) | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million | 1.41 Million |
Gross Margin | 0.50 | 0.50 | 0.44 | 0.43 | 0.44 | 0.45 |
EBIT Margin | 0.16 | 0.16 | 0.17 | - | 0.17 | 0.13 |
Profit Margin | 0.10 | 0.10 | 0.12 | 0.10 | 0.12 | 0.07 |
EBITDA | 2.39 Million | 2.39 Million | 2.65 Million | - | 2.65 Million | 3.82 Million |
Earnings Before Tax Margin | 0.11 | 0.11 | 0.12 | 0.10 | 0.12 | 0.07 |
EUROB
105560
POLICYBZR
1802
YOU
ACGL